Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Study to Assess the Long-term Safety and Efficacy of Osilodrostat in Patients With Endogenous Cushing's Syndrome

NCT05382156 is registered in ClinicalTrials.gov with RECORDATI GROUP as lead sponsor.

NCT NCT05382156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05382156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Study to Assess the Long-term Safety and Efficacy of Osilodrostat in Patients With Endogenous Cushing's Syndrome
Lead sponsor
RECORDATI GROUP
Phase
Observational
Overall status
Active, not recruiting
Start date
June 13, 2022
Completion date
August 31, 2027
Enrollment
206 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

endogenous cushing's syndrome